Public Policy News
was invited by the New Jersey Board of Pharmacy to attend the October 23, 2019
public meeting and provide additional feedback about our October 1, 2019 letter
regarding compounding regulations.
Paul Goebel (Director of Public
Policy) and I attended this meeting, which also included comments on this issue
from our colleagues at NJPhA. NJSHP also offered to work with the Board
of Pharmacy to develop specific guidance tools for all our pharmacists in New
Jersey who provide compounding services to their patients. The Board
thanked us for our advocacy in this area, and the Board chair acknowledged that
further guidance is needed soon.
As we move forward with our advocacy
agenda, I will ensure there is continued dialogue with the Board on all matters
related to hospital pharmacy practice that will benefit pharmacists, pharmacy
technicians, and most importantly, the patients that we provide care for.
Philips, Pharm.D., B.S.